Homo sapiens Protein: PLG | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||||||||||
InnateDB Protein | IDBP-98753.5 | ||||||||||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||||||||||
Gene Symbol | PLG | ||||||||||||||||||||||||||||||
Protein Name | plasminogen | ||||||||||||||||||||||||||||||
Synonyms | |||||||||||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||||||||||
Ensembl Protein | ENSP00000308938 | ||||||||||||||||||||||||||||||
InnateDB Gene | IDBG-98749 (PLG) | ||||||||||||||||||||||||||||||
Protein Structure | |||||||||||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||||||||||
Function | Plasmin dissolves the fibrin of blood clots and acts as a proteolytic factor in a variety of other processes including embryonic development, tissue remodeling, tumor invasion, and inflammation. In ovulation, weakens the walls of the Graafian follicle. It activates the urokinase-type plasminogen activator, collagenases and several complement zymogens, such as C1 and C5. Cleavage of fibronectin and laminin leads to cell detachment and apoptosis. Also cleaves fibrin, thrombospondin and von Willebrand factor. Its role in tissue remodeling and tumor invasion may be modulated by CSPG4. Binds to cells. {ECO:0000269PubMed:14699093}.Angiostatin is an angiogenesis inhibitor that blocks neovascularization and growth of experimental primary and metastatic tumors in vivo. {ECO:0000269PubMed:14699093}. | ||||||||||||||||||||||||||||||
Subcellular Localization | Secreted {ECO:0000269PubMed:10077593, ECO:0000269PubMed:14699093}. Note=Locates to the cell surface where it is proteolytically cleaved to produce the active plasmin. Interaction with HRG tethers it to the cell surface. | ||||||||||||||||||||||||||||||
Disease Associations | Plasminogen deficiency (PLGD) [MIM:217090]: A disorder characterized by decreased serum plasminogen activity. Two forms of the disorder are distinguished: type 1 deficiency is additionally characterized by decreased plasminogen antigen levels and clinical symptoms, whereas type 2 deficiency, also known as dysplasminogenemia, is characterized by normal, or slightly reduced antigen levels, and absence of clinical manifestations. Plasminogen deficiency type 1 results in markedly impaired extracellular fibrinolysis and chronic mucosal pseudomembranous lesions due to subepithelial fibrin deposition and inflammation. The most common clinical manifestation of type 1 deficiency is ligneous conjunctivitis in which pseudomembranes formation on the palpebral surfaces of the eye progresses to white, yellow-white, or red thick masses with a wood-like consistency that replace the normal mucosa. {ECO:0000269PubMed:10233898, ECO:0000269PubMed:1427790, ECO:0000269PubMed:1986355, ECO:0000269PubMed:6216475, ECO:0000269PubMed:6238949, ECO:0000269PubMed:8392398, ECO:0000269PubMed:9242524, ECO:0000269PubMed:9858247}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||||||||||||||
Tissue Specificity | Present in plasma and many other extracellular fluids. It is synthesized in the liver. | ||||||||||||||||||||||||||||||
Comments | |||||||||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 46 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
|
||||||||||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||||||||||
InterPro |
IPR000001
Kringle IPR001254 Peptidase S1 IPR001314 Peptidase S1A, chymotrypsin-type IPR003014 PAN-1 domain IPR003609 Apple-like IPR009003 Trypsin-like cysteine/serine peptidase domain IPR013806 Kringle-like fold IPR015420 Peptidase S1A, nudel IPR023317 Peptidase S1A, plasmin |
||||||||||||||||||||||||||||||
PFAM |
PF00051
PF00089 PF00024 PF09342 |
||||||||||||||||||||||||||||||
PRINTS |
PR00722
|
||||||||||||||||||||||||||||||
PIRSF |
PIRSF001150
|
||||||||||||||||||||||||||||||
SMART |
SM00130
SM00020 SM00473 |
||||||||||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||||||||||
Modification | |||||||||||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||||||||||
SwissProt | P00747 | ||||||||||||||||||||||||||||||
PhosphoSite | PhosphoSite-P00747 | ||||||||||||||||||||||||||||||
TrEMBL | Q9UMI2 | ||||||||||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||||||||||
Entrez Gene | 5340 | ||||||||||||||||||||||||||||||
UniGene | Hs.143436 | ||||||||||||||||||||||||||||||
RefSeq | NP_000292 | ||||||||||||||||||||||||||||||
HUGO | HGNC:9071 | ||||||||||||||||||||||||||||||
OMIM | 173350 | ||||||||||||||||||||||||||||||
CCDS | CCDS5279 | ||||||||||||||||||||||||||||||
HPRD | 01417 | ||||||||||||||||||||||||||||||
IMGT | |||||||||||||||||||||||||||||||
EMBL | AK298338 AL109933 AY192161 BC060513 CH471051 CR749293 K02921 K02922 M33272 M33274 M33275 M33278 M33279 M33280 M33282 M33283 M33284 M33285 M33286 M33287 M33288 M33289 M33290 M34272 M34273 M34275 M34276 M74220 X05199 | ||||||||||||||||||||||||||||||
GenPept | AAA36451 AAA60113 AAA60123 AAA60124 AAH60513 AAN85555 BAG60586 CAA28831 CAH18148 CAI22908 EAW47592 | ||||||||||||||||||||||||||||||